The company’s oral, microbiome-changing therapy was well tolerated in patients with amyotrophic lateral sclerosis.

MaaT Pharma Announces Positive Phase 1b Results, Meeting Primary Endpoint in the Evaluation of MaaT033 in Amyotrophic Lateral ...

KIIT-DU ( has secured an impressive 4th position in India in the inaugural Times Higher Education (THE) Interdisciplinary Science Rankings 2025, which recognizes universities excelling in ...

ActivTrak today announced it is No. 468 on the Deloitte Technology Fast 500tm, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech and energy tech ...

MaaT Pharma’s quest to bring a microbiota-based therapy to market has moved a step forward with new data showing a benefit for its MaaT013 candidate in an early-access programme (EAP).

The hearing, held to discuss land acquisition for a proposed ‘Pharma Village’ project by the Telangana government, turned chaotic when residents, mainly from Roti Banda thanda and Pulicheru ...

16:08 EST BridgeBio (BBIO) Pharma trading halted, news pending Don't Miss our Black Friday Offers: Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments ...

In a report released yesterday, Anupam Rama from J.P. Morgan maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report), with a price target of $40.00. The company’s shares closed ...

Marksans Pharma Ltd shares increased 3.2% on Friday, November 22, after the firm received final approval from the US Food and Drug Administration (USFDA) for its Loratadine Tablets, which are used ...

As a company focused on delivering a re-purposed erectile dysfunction drug via a nasal spray, LTR Pharma is a simple story to understand. Tim Boreham evaluates. But there are circumstances when ...

Aurobindo Pharma: The pharma company’s US subsidiary, Aurobindo Pharma USA Inc, has entered into a Collaboration and License Agreement with a global pharma major for the development of specific ...